Prof Elmir Omerovic (University of Gothenburg, Gothenburg, SE) discusses updates from SCAAR registry - Pretreatment with P2Y12 Receptor Antagonists is not Associated with Improved Clinical Outcomes in UA/NSTEMI.
Filmed on-site at ESC 2018, Munich.
Video
ESC 2018: Report From the SCAAR Registry
Published: 14 Sep 2018
-
Views:
351
-
Likes:
0